Chapter 3 Aortic Aneurysm
- Aortic Aneurysm
- Causes and Risk Factors
- Aging, Gender and Aortic Aneurysms
- Global Demographics
- U.S. Demographics
- European Demographics
- Japanese Demographics
Chapter 4 Abdominal Aortic Aneurysms
- Disease Overview
- Types of AAA
- Infrarenal Aortic Aneurysms
- Juxtarenal Aortic Aneurysms
- Suprarenal Aortic Aneurysms
- Slow-Growing AAAs
- Fast-Growing AAAs
- Risk Factors and Symptoms
- Epidemiology and Economic Burden
- Diagnosis
- Treatment
- Open Surgical Repair
- Endovascular Aortic Repair (EVAR or EVAS)
- Hybrid Approach
- EVAR Versus Open Surgical Repair
- Key Marketed and Pipeline Products
- Key Marketed Products
- Key Pipeline/R&D Products
- Unmet Need
- Current Challenges and Future Developments
Chapter 5 Thoracic Aortic Aneurysms
- Disease Overview
- Types of TAA by Shape
- Types of TAA by Location/Segment
- Thoracoabdominal Aortic Aneurysms
- Risk Factors and Symptoms
- Epidemiology and Economic Burden
- Diagnosis
- Treatment
- Open Surgical Repair
- Thoracic Endovascular Aortic Repair (TEVAR)
- Hybrid Approach
- TEVAR Versus Open Surgical Repair
- Aortic Dissection
- Disease Overview
- Risk Factors and Symptoms
- Epidemiology
- Diagnosis and Treatment
- Key Marketed and Pipeline Products
- Key Marketed Products
- Key Pipeline/R&D Products
- Current Challenges and Future Developments
Chapter 6 Market Size and Growth Analysis
- Market Size and Growth Analysis
- Market Size and Growth Analysis by Region
- Market Size and Growth Analysis by Segment
- Market Size and Growth Analysis by Aneurysm Location
- Market Size and Growth Analysis by Aneurysm Type
- Market Growth Drivers and Restraints
- Market Growth Drivers
- Market Restraints
Chapter 7 Competitive Landscape in Endovascular Treatment Market
- Competitive Landscape in Endovascular Treatment Market
Chapter 8 Market Strategies in the Endovascular Treatment Market
- Recent Mergers and Acquisitions
- Terumo Acquired Bolton Medical
- Endologix and TriVascular Technologies Completed Merger
- Cardinal Health Acquired Johnson & Johnson’s Cordis Business
- Lombard Medical Acquired Altura Medical
- Medtronic Acquired Aptus Endosystems
- Endologix Acquired Nellix
- Boston Scientific Acquired TriVascular Technologies
- LeMaitre Vascular Acquired Endomed
- Endologix Merged with Radiance Medical
- Johnson & Johnson (J&J) Through its Subsidiary Cordis Acquired TERAMed
- Future Strategic Landscape
Chapter 9 Regulatory Structure: Medical Devices
- Regulatory Background
- Regulatory Systems for Medical Devices by Country/Region
- U.S.
- European Union (EU)
- Japan
Chapter 10 Pricing and Reimbursement: Medical Devices
- Pricing and Reimbursement Background
- Pricing and Reimbursement for Medical Devices by Country/Region
- U.S.
- Europe
- Japan
Chapter 11 Conclusions-Outlook for Endovascular Treatment Devices
- Major Developments Influencing the Market
- Technological Developments
- Demographic and Economic Trends
- Changing Structure of the Healthcare Industry
- Long-Term Outlook for Endovascular Treatment
Chapter 12 Company Profiles
- Altura Medical (Subsidiary Of Lombard Medical)
- Biflow Medical
- Blockade Medical Llc (Subsidiary Of Balt International)
- Bolton Medical Inc. (Subsidiary Of Vascutek Terumo)
- Boston Scientific Corp.
- Braile Biomedica
- Cardiatis Sa
- Cardinal Health
- Cook Group Inc.
- Cordis Corp. (Subsidiary Of Cardinal Health Inc.)
- Endologix
- Endoluminal Sciences Pty Ltd.
- Endomed (Subsidiary Of Lemaitre Vascular)
- Endospan
- Getinge Ab
- Inspiremd
- Japan Lifeline Co. Ltd.
- Kawasumi Laboratories
- Lemaitre Vascular Inc.
- Lifetech Scientific
- Lombard Medical Technologies
- Medtronic
- Microport Scientific
- Microvention (Subsidiary Of Terumo)
- Micrus Endovascular (Subsidiary Of Johnson & Johnson)
- Nellix Inc. (Subsidiary Of Endologix)
- Penumbra
- Terumo Corp.
- Transcatheter Technologies
- Trivascular Technologies (Subsidiary Of Endologix Inc.)
- W.L. Gore And Associates
Chapter 14 Appendix B: Professional Organizations
- American Heart Association
- Center for Drug Evaluation and Research (CDER)
- Center for Devices and Radiological Health (CDRH)
- Centers for Medicare & Medicaid Services (CMS)
- European Databank for Medical Devices (EUDAMED)
- Food and Drug Administration (FDA or USFDA)
- Hormone Foundation
- International Diabetes Federation (IDF)
- International Federation of Pharmaceutical Manufacturers & Associations (IFPMA)
- Network for Excellence in Health Innovation (NEHI)
- National Center for Biotechnology Information (NCBI)
- National Institute of Aging (NIA)
- Pharmaceuticals and Medical Devices Agency (PMDA)
- World Cancer Research Fund International
- World Health Organization (WHO)
List of Tables
Summary Table: Global Market for Endovascular Treatment Devices, by Region, Through 2022
Table 1: Epidemiology, TAA vs. AAA
Table 2: Leading Peripheral Vascular Disease Conditions, by Type
Table 3: Global Prevalence of Peripheral Artery Disease, Through 2020
Table 4: Global Incidence Shares of Hypertension, by Patient Group, 2016
Table 5: BMI Calculation
Table 6: BMI Categories Based on Increasing Health Risks
Table 7: Trends in Obesity Composition of the World's Population, Through 2021
Table 8: U.S. Obese and Severely Obese vs. General Population, Through 2021
Table 9: Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 10: World Population, by Region, Through 2030
Table 11: U.S. Population Estimates and Projections, by Age Group, Through 2030
Table 12: Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, Through 2020
Table 13: European Population Estimates and Projections, by Age Group, Through 2030
Table 14: Japanese Population Estimates and Projections, by Age Group, Through 2030
Table 15: Prevalence of AAA, Global vs. U.S., Through 2022
Table 16: Imaging Techniques for AAA Diagnosis
Table 17: Size of AAA, Estimated Annual Risk of Rupture
Table 18: Key Marketed Products, Endovascular Systems for AAA
Table 19: Key Pipeline/R&D Products, Endovascular Systems for AAA
Table 20: Prevalence of TAA, Global vs. U.S., Through 2022
Table 21: Key Marketed Products, Endovascular Systems for TAA
Table 22: Key Pipeline/R&D Products, Endovascular Systems for TAA
Table 23: Global Market for Endovascular Treatment Devices, by Region, Through 2022
Table 24: Global Market for Endovascular Treatment Devices, by Segment, Through 2022
Table 25: Global Market for Aneurysm Repair (EVAR and Open Surgical Repair), by Aneurysm Type, Through 2022
Table 26: Global Market for Endovascular Treatment Devices, by Leading Company, 2016
Table 27: Recent Key Strategic Deals in Endovascular Treatment Market
Table 28: Differences in Regulatory Approval in the U.S. and Europe
Table 29: Endovascular Procedures, Billing and Reimbursement, U.S.
Table 30: Operations on Abdominal Aorta, ICD-10 Procedure Codes
Table 31: Hospital Inpatient Procedures Utilizing MS-DRGs, National Average Reimbursement, CMS
Table 32: Trends in Per Capita Real GDP Growth, by Region, 2012-2016
Table 33: List of Acronyms
List of Figures
Summary Figure: Global Market for Endovascular Treatment Devices, by Region, 2016-2022
Figure 1: Global Prevalence of Peripheral Artery Disease, 2000-2020
Figure 2: Global Incidence Shares of Hypertension, by Patient Group, 2016
Figure 3: Trends in Obesity Composition of the World's Population, 2012-2021
Figure 4: U.S. Obese and Severely Obese vs. General Population, 2016 and 2021
Figure 5: Estimated World Population and Annual Growth, by Selected Age Group, 2000-2030
Figure 6: World Population, by Region, 2000-2030
Figure 7: U.S. Population Estimates and Projections, by Age Group, 2000-2030
Figure 8: Estimates of Anticipated U.S. Life Expectancy at Birth, by Gender, 2005-2020
Figure 9: European Population Estimates and Projections, by Age Group, 2000-2030
Figure 10: Japanese Population Estimates and Projections, by Age Group, 2000-2030
Figure 11: Prevalence of AAA, Global vs. U.S., 2016-2022
Figure 12: Prevalence of TAA, Global vs. U.S., 2016-2022
Figure 13: Global Market for Endovascular Treatment Devices, by Region, 2016-2022
Figure 14: Global Market for Endovascular Treatment Devices, by Segment, 2016-2022
Figure 15: Global Market Shares for EVAR and TEVAR, by Aneurysm Location, 2017
Figure 16: Global Market Shares for EVAR and TEVAR, by Aneurysm Complexity, 2017
Figure 17: Global Market for Aneurysm Repair (EVAR and Open Surgical Repair), by Aneurysm Type, 2016-2022
Figure 18: Global Market Shares for Aortic Repair Procedures, by Surgery Type, 2017
Figure 19: Global Market Shares for Endovascular Treatment Devices, by Leading Company, 2016
Figure 20: Trends in Per Capita Real GDP Growth, by Region, 2012-2016"
